,

Study Demonstrates Promise for Olaparib in Metastatic Castration-Resistant Prostate Cancer

Olaparib was found to be associated with longer progression-free survival and improved measures of response and patient-reported end points than either enzalutamide or abiraterone in men with metastatic castration-resistant prostate cancer. (Source: CancerNetwork)

CancerNetwork

8h

Population Genomic Screening Efforts May Identify High-Risk Individuals Before Disease Onset

According to researchers, these observations suggest a potential need to modify the current framework for clinical risk disclosure. (Source: CancerNetwork)

CancerNetwork

8h

Improved Risk Models Identify People at Higher than Normal Risk of Pancreatic Cancer

Researchers demonstrated that risk models that include established clinical, genetic, and circulating factors are better able to identify people at significantly higher than normal risk of pancreatic cancer over those using clinical factors alone. (Source: CancerNetwork)

CancerNetwork

8h

Fiber Consumption May be Associated with Reduced Breast Cancer Risk

The results from this random-effects meta-analysis suggested that dietary fiber intake may decrease the risk of breast cancer, including both premenopausal and postmenopausal breast cancers. (Source: CancerNetwork)

CancerNetwork

8h